IV 
112TH CONGRESS 
2D SESSION 
H. CON. RES. 120 
Supporting the goal of preventing and effectively treating Alzheimer’s disease 
by the year 2025, as articulated in the draft National Plan to Address 
Alzheimer’s Disease from the Department of Health and Human Serv-
ices. 
IN THE HOUSE OF REPRESENTATIVES 
APRIL 24, 2012 
Mr. MARKEY (for himself, Mr. SMITH of New Jersey, Mr. BURGESS, Mr. 
TOWNS, Mr. GRIJALVA, Ms. SPEIER, Mr. RANGEL, Mrs. MALONEY, Mr. 
LEWIS of Georgia, Mr. LEVIN, Mr. RAHALL, and Mr. LOBIONDO) sub-
mitted the following concurrent resolution; which was referred to the 
Committee on Energy and Commerce 
CONCURRENT RESOLUTION 
Supporting the goal of preventing and effectively treating 
Alzheimer’s disease by the year 2025, as articulated in 
the draft National Plan to Address Alzheimer’s Disease 
from the Department of Health and Human Services. 
Whereas Alzheimer’s disease is the sixth leading cause of 
death in the United States; 
Whereas Alzheimer’s disease is the only disease among the 10 
leading causes of death in the United States that lacks 
a means of prevention or a cure, and the progression of 
which cannot be slowed; 
VerDate Mar 15 2010 
21:23 Apr 25, 2012
Jkt 019200
PO 00000
Frm 00001
Fmt 6652
Sfmt 6300
E:\BILLS\HC120.IH
HC120
srobinson on DSK4SPTVN1PROD with BILLS
•HCON 120 IH 
Whereas more than 5,000,000 people in the United States 
suffer from Alzheimer’s disease; 
Whereas, in 2011, 15,200,000 family members and friends 
provided 17,400,000,000 hours of unpaid care valued at 
$210,500,000,000 to patients with Alzheimer’s disease 
and other dementias; 
Whereas, by the year 2050, as many as 15,000,000 people 
in the United States will have Alzheimer’s disease if sci-
entists do not make progress in the prevention or treat-
ment of the disease; 
Whereas the Federal Government spent an estimated 
$140,000,000,000 under the Medicare and Medicaid pro-
grams to care for patients with Alzheimer’s disease in 
2011; 
Whereas spending relating to the treatment of Alzheimer’s 
disease under the Medicare and Medicaid programs is 
projected to be more than $850,000,000,000 per year, in 
2012 dollars, by the year 2050; 
Whereas scientists working to find a cure for Alzheimer’s dis-
ease have already identified— 
(1) more than 100 genes linked to Alzheimer’s dis-
ease; 
(2) biomarkers to identify the people who are at risk 
for Alzheimer’s disease; and 
(3) other promising leads in gene, protein, and drug 
therapies to benefit people who have Alzheimer’s disease 
or are at risk of developing the disease; 
Whereas an emphasis on early diagnosis, workforce training, 
education, and support for patients and the families of 
patients, as well as other programs and initiatives spear-
headed by State and local governments, advocacy organi-
VerDate Mar 15 2010 
21:23 Apr 25, 2012
Jkt 019200
PO 00000
Frm 00002
Fmt 6652
Sfmt 6300
E:\BILLS\HC120.IH
HC120
srobinson on DSK4SPTVN1PROD with BILLS
•HCON 120 IH 
zations, doctors, hospitals, and long-term care facilities, 
are already making a difference in reducing the burden 
of Alzheimer’s disease for patients, families, and commu-
nities; 
Whereas the National Alzheimer’s Project Act (Public Law 
111–375; 124 Stat. 4100), which Congress passed unani-
mously on December 15, 2010 and President Barack 
Obama signed into law on January 4, 2011, required the 
Secretary of Health and Human Services to create the 
first National Plan to Address Alzheimer’s Disease, and 
established the Advisory Council on Alzheimer’s Re-
search, Care, and Services to assist the Secretary of 
Health and Human Services in this task; 
Whereas, shortly after the National Alzheimer’s Project Act 
was enacted, the Department of Health and Human 
Services created the Interagency Group on Alzheimer’s 
Disease and Related Dementias to inform the National 
Plan to Address Alzheimer’s Disease; 
Whereas, in formulating the draft National Plan to Address 
Alzheimer’s Disease, the Department of Health and 
Human Services, the Interagency Group on Alzheimer’s 
Disease and Related Dementias, and the Advisory Coun-
cil on Alzheimer’s Research, Care, and Services focused 
on 3 main topics, long-term services and support, clinical 
care, and research; and 
Whereas the draft National Plan to Address Alzheimer’s Dis-
ease includes— 
(1) the bold and transformative goal of preventing 
or treating Alzheimer’s disease by the year 2025; and 
(2) specific performance metrics to optimize the 
quality and efficiency of care, expand support for patients 
and families, enhance public awareness and engagement, 
VerDate Mar 15 2010 
21:23 Apr 25, 2012
Jkt 019200
PO 00000
Frm 00003
Fmt 6652
Sfmt 6300
E:\BILLS\HC120.IH
HC120
srobinson on DSK4SPTVN1PROD with BILLS
•HCON 120 IH 
track progress, and drive improvement: Now, therefore, 
be it 
Resolved by the House of Representatives (the Senate 
concurring), That Congress— 
(1) supports the groundbreaking national goal 
of preventing and treating Alzheimer’s disease by 
the year 2025 and the other goals of the draft Na-
tional Plan to Address Alzheimer’s Disease; 
(2) finds that basic science, medical research, 
and therapy development, through enhanced re-
search programs and expanded public-private part-
nerships, are necessary for— 
(A) reaching the goal of preventing and 
treating Alzheimer’s disease by the year 2025; 
and 
(B) identifying a definitive cure for Alz-
heimer’s disease; 
(3) calls for further public awareness and un-
derstanding of Alzheimer’s disease; 
(4) supports increased assistance for people 
with Alzheimer’s disease and the caregivers and fam-
ilies of those people; and 
(5) encourages early diagnosis and access to 
high-quality care for people with Alzheimer’s disease. 
Æ 
VerDate Mar 15 2010 
21:23 Apr 25, 2012
Jkt 019200
PO 00000
Frm 00004
Fmt 6652
Sfmt 6301
E:\BILLS\HC120.IH
HC120
srobinson on DSK4SPTVN1PROD with BILLS